News
Iodine, Waystar and Medical software
Digest more
Waystar to acquire Iodine Software for $1.25 billion to enhance AI tools; deal expected to be accretive to growth and margins by 2027.
This stock is worth watching for several compelling reasons, including a gamechanging acquisition, ahead of its upcoming earnings.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback